Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
Pralidoxime chloride is an oxime-based antidote administered by injection used to treat poisoning from organophosphate compounds and certain carbamate pesticides. It works by reactivating acetylcholinesterase inhibited by these toxic agents, restoring normal neuromuscular function. This is a critical emergency-use therapeutic with narrow but essential clinical applications.
As a 40+ year-old product nearing loss of exclusivity, the brand team is likely small and focused on maintaining market position through competitive pricing and hospital/emergency preparedness channels rather than growth expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on pralidoxime offers a stable but specialized career path focused on niche market management, regulatory compliance, and emergency preparedness channels rather than traditional pharma growth. As the product approaches LOE, career opportunities center on defending market position, pricing strategy, and ensuring continuity of supply to hospitals and emergency responders.
Worked on PRALIDOXIME CHLORIDE at Baxter International? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.